Dr. Michael Scott Ingber, MD

Dr. Ingber practices at Atlantic Medical Group in Denville, New Jersey.

Dr. Ingber's NPI, 1861606329, was assigned on May 10, 2007. Dr. Ingber graduated from Wayne State University School of Medicine in 2002. Dr. Ingber holds New Jersey license 25MA08730700.

Dr. Ingber's primary practice is Atlantic Medical Group, at 3155 State Highway 10, Denville, NJ 07834. The practice phone is (844) 264-2250.

Dr. Ingber's primary practice is Atlantic Medical Group in Denville, New Jersey. Dr. Ingber is also affiliated with Morristown Medical Center. The medical group on file is Atlantic Medical Group. Dmand AI also links Dr. Ingber to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ingber practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Ingber's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Ingber's licenses on file in 2 states: New Jersey and Michigan.

CMS data shows 2,308 Medicare services from Dr. Ingber across 22 procedure codes in 2024, for 658 Medicare patients. Medicare paid $218,881 for them.

CMS counts 658 Medicare patients who saw Dr. Ingber in 2024. The largest group is 75 to 84, with 272 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ingber's median patient age at 68, with 88% women.

In 2024, Dr. Ingber wrote 1,577 Medicare Part D claims for 521 patients. 62% of them were for generic drugs. CMS names the drug for 1,453 of them, across 21 drugs with 11 or more claims each, at $389,240 in total drug cost. In 2023, CMS named 1,421 claims across 22 drugs.

Dr. Ingber accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ingber as offering telehealth.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Ingber, published from 2006 to 2018. 2009 was the busiest year, with 2. The most frequent topics are Postoperative Complications, Urinary Incontinence and Pelvic Pain. Dr. Ingber has published most often in Urology. Dr. Ingber's most frequent co-authors are Farzeen Firoozi, MD, Ryan M. Krlin, MD and Raymond R. Rackley, MD.

Dmand AI links Dr. Ingber to 1 clinical trial. Conditions studied include Pelvic Organ Prolapse and Prolapse.

CMS Open Payments shows 714 general payments to Dr. Ingber from 60 drug and device companies from 2016 to 2025. Acquisitions make up the largest share, 71% of the total. Becton, Dickinson and Company paid the most, $431,027. It also lists 2 research payments totaling $297 in 2023.

Dr. Ingber graduated from Wayne State University School of Medicine in 2002.